SY-1365 also potently kills tumor cell lines, particularly of leukemic origin (26), and our data now highlight the dual potential of CDK7 inhibitors as chemotherapeutic agents and antifungals, particularly in blood cancer patients at risk of opportunistic infections, including with Cn (59). This evidence concerns the gene CDK7 and hematopoietic and lymphoid system neoplasm.